Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia

British Journal of Haematology

Volumn 166, Issue 3, 2014, Pages 390-400

  Cornet, Edouard ^a,b   Tomowiak, Cécile ^c   Tanguy Schmidt, Aline ^d   Lepretre, Stéphane ^e   Dupuis, Jehan ^f   Feugier, Pierre ^g   Devidas, Alain ^h   Mariette, Clara ⁱ   Leblond, Véronique ^j   Thiéblemont, Catherine ^k   Validire Charpy, Patricia ^l   Sutton, Laurent ^m   Gyan, Emmanuel ⁿ   Eisenmann, Jean Claude ^o   Cony Makhoul, Pascale ^p   Ysebaert, Loïc ^q   Troussard, Xavier ^a,b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e Centre de Lutte Contre le Cancer Henri Becquerel   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h CENTRE HOSPITALIER SUD FRANCILIEN   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l INSTITUT CURIE   (France)

^m CENTRE HOSPITALIER VICTOR DUPOUY   (France)

ⁿ UNIVERSITÉ DE TOURS   (France)

^o Mulhouse Hospital   (France)

^p Annecy Hospital   (France)

^q TOULOUSE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Hairy cell leukaemia; Purine nucleoside analogues; Second malignancies

Indexed keywords

CLADRIBINE; INTERFERON; PENTOSTATIN; PURINE NUCLEOSIDE DERIVATIVE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BLADDER CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FOLLICULAR LYMPHOMA; FOLLOW UP; FRANCE; HAIRY CELL LEUKEMIA; HEAD AND NECK CANCER; HUMAN; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LEUKEMIA RELAPSE; LUNG CANCER; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; MEDICAL RECORD REVIEW; MELANOMA; MONOCLONAL IMMUNOGLOBULINEMIA; OVERALL SURVIVAL; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROSTATE CANCER; SECOND CANCER; STANDARDIZED INCIDENCE RATIO; SURVIVAL TIME; TESTIS CANCER; THYROID CANCER; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

HAIRY CELL LEUKAEMIA; PURINE NUCLEOSIDE ANALOGUES; SECOND MALIGNANCIES;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG SUBSTITUTION; FOLLOW-UP STUDIES; FRANCE; HUMANS; LEUKEMIA, HAIRY CELL; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84904052167     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12908     Document Type: Article

References (43)

1. Anonymous (1987) Consensus resolution: proposed criteria for evaluation of response to treatment in hairy cell leukemia. Leukemia, 1, 405.
2. Au, W.Y., Klasa, R.J., Gallagher, R., Le, N., Gascoyne, R.D. & Connors, J.M. (1998) Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience. Blood, 92, 1160-1164.
3. Belot, A., Grosclaude, P., Bossard, N., Jougla, E., Benhamou, E., Delafosse, P., Guizard, A., Molinie, F., Danzon, A., Bara, S., Bouvier, A., Tretarre, B., Binder-Foucard, F., Colonna, M., Daubisse, L., Hedelin, G., Launoy, G., Le Stang, N., Maynadie, M., Monnereau, A., Troussard, X., Faivre, J., Collignon, A., Janoray, I., Arveux, P., Buemi, A., Raverdy, N., Schvartz, C., Bovet, M., Cherie-Challine, L., Esteve, J., Remontet, L. & Velten, M. (2008) Cancer incidence and mortality in France over the period 1980-2005. Revue d'Epidemiologie et de Sante Publique, 56, 159-175.
4. Bernstein, L., Newton, P. & Ross, R.K. (1990) Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Research, 50, 3605-3609.
5. Bigda, J., Mysliwska, J., Baran, W., Hellmann, A. & Mysliwski, A. (1993) Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia. Leukaemia & Lymphoma, 9, 371-376.
6. Bourguin-Plonquet, A., Rouard, H., Roudot-Thoraval, F., Bellanger, C., Marquet, J., Delfau-Larue, M.H., Divine, M. & Farcet, J.P. (2002) Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia. British Journal of Haematology, 116, 595-597.
7. Bouroncle, B.A., Wiseman, B.K. & Doan, C.A. (1958) Leukemic reticuloendotheliosis. Blood, 13, 609-630.
8. Cheson, B.D., Sorensen, J.M., Vena, D.A., Montello, M.J., Barrett, J.A., Damasio, E., Tallman, M., Annino, L., Connors, J., Coiffier, B. & Lauria, F. (1998) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. Journal of Clinical Oncology, 16, 3007-3015.
9. Cheson, B.D., Vena, D.A., Barrett, J. & Freidlin, B. (1999) Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. Journal of Clinical Oncology, 17, 2454-2460.
10. van de Corput, L., Falkenburg, J.H., Kester, M.G., Willemze, R. & Kluin-Nelemans, J.C. (1999) Impaired expression of CD28 on T cells in hairy cell leukemia. Clin Immunol, 93, 256-262.
11. Dearden, C.E., Else, M. & Catovsky, D. (2011) Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. Leukaemia & Lymphoma, 52 (Suppl. 2), 21-24.
12. Diaz-Pavon, J.R., Pugh, W. & Cabanillas, F. (1995) Simultaneous presentation of hairy cell leukemia and follicular small cleaved cell lymphoma in a patient with previous diagnosis of renal cell carcinoma. Hematological Oncology, 13, 63-67.
13. Else, M., Ruchlemer, R., Osuji, N., Del Giudice, I., Matutes, E., Woodman, A., Wotherspoon, A., Swansbury, J., Dearden, C. & Catovsky, D. (2005) Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer, 104, 2442-2448.
14. Else, M., Dearden, C.E., Matutes, E., Garcia-Talavera, J., Rohatiner, A.Z., Johnson, S.A., O'Connor, N.T., Haynes, A., Osuji, N., Forconi, F., Lauria, F. & Catovsky, D. (2009) Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. British Journal of Haematology, 145, 733-740.
15. Else, M., Dearden, C.E., Matutes, E., Forconi, F., Lauria, F., Ahmad, H., Kelly, S., Liyanage, A., Ratnayake, V., Shankari, J., Whalley, I. & Catovsky, D. (2011) Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leukaemia & Lymphoma, 52 (Suppl. 2), 75-78.
16. Emilia, G., Luppi, M., Gandini, G., Bertesi, M. & Torelli, G. (1995) Hairy cell leukaemia, second cancer and occupational risk. British Journal of Haematology, 91, 518-519.
17. Federico, M., Zinzani, P.L., Frassoldati, A., Vinceti, M., Mode, A., Annino, L., Chisesi, T., Pagnucco, G., Invernizzi, R., Spriano, M., Resegotti, L., Bendandi, M. & Damasio, E.E. (2002) Risk of second cancer in patients with hairy cell leukemia: long-term follow-up. Journal of Clinical Oncology, 20, 638-646.
18. Flinn, I.W., Kopecky, K.J., Foucar, M.K., Head, D., Bennett, J.M., Hutchison, R., Corbett, W., Cassileth, P., Habermann, T., Golomb, H., Rai, K., Eisenhauer, E., Appelbaum, F., Cheson, B. & Grever, M.R. (2000) Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood, 96, 2981-2986.
19. Foucar, K., Falini, B., Catovsky, D. & Stein, H. (2008) Hairy cell leukaemia. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W.), pp. 188-190. Lyon, IARC.
20. Goodman, G.R., Burian, C., Koziol, J.A. & Saven, A. (2003) Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. Journal of Clinical Oncology, 21, 891-896.
21. Grever, M.R. & Lozanski, G. (2011) Modern strategies for hairy cell leukemia. Journal of Clinical Oncology, 29, 583-590.
22. Grever, M., Kopecky, K., Foucar, M.K., Head, D., Bennett, J.M., Hutchison, R.E., Corbett, W.E., Cassileth, P.A., Habermann, T., Golomb, H., Rai, K., Eisenhauer, E., Appelbaum, F. & Cheson, B. (1995) Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. Journal of Clinical Oncology, 13, 974-982.
23. Hisada, M., Chen, B.E., Jaffe, E.S. & Travis, L.B. (2007) Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. Journal of the National Cancer Institute, 99, 215-222.
24. Jacobs, R.H., Vokes, E.E. & Golomb, H.M. (1985) Second malignancies in hairy cell leukemia. Cancer, 56, 1462-1467.
25. Jones, G., Parry-Jones, N., Wilkins, B., Else, M. & Catovsky, D. (2012) Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant. British Journal of Haematology, 156, 186-195.
26. Kampmeier, P., Spielberger, R., Dickstein, J., Mick, R., Golomb, H. & Vardiman, J.W. (1994) Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood, 83, 2931-2938.
27. Kluin-Nelemans, J.C., Kester, M.G., Melenhorst, J.J., Landegent, J.E., van de Corput, L., Willemze, R. & Falkenburg, J.H. (1996) Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood, 87, 3795-3802.
28. Kurzrock, R., Strom, S.S., Estey, E., O'Brien, S., Keating, M.J., Jiang, H., Adams, T. & Talpaz, M. (1997) Second cancer risk in hairy cell leukemia: analysis of 350 patients. Journal of Clinical Oncology, 15, 1803-1810.
29. Kwong, Y.L., Liang, R., Chiu, E., Chan, D.W. & Chan, T.K. (1995) Hairy cell leukemia: treatment results and association with secondary malignancy. American Journal of Hematology, 48, 291.
30. Lopera, G.A., Alvarez, O.A. & Lee, M. (1995) Large cell lymphoma of the colon presenting as a second malignancy in a patient with hairy cell leukemia. Journal of Clinical Gastroenterology, 21, 259-260.
31. Maloisel, F., Benboubker, L., Gardembas, M., Coiffier, B., Divine, M., Sebban, C., Blanc, M., Abgrall, J.F., Lederlin, P., Harousseau, J.L., Blaise, A.M., Grosbois, B., Morice, P., Ghandour, C. & Castaigne, S. (2003) Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia, 17, 45-51.
32. Nakamura, Y., Machii, T., Tokumine, Y., Inoue, R., Shibano, M., Nojima, J., Kimura, F., Toyama, K. & Kitani, T. (1993) Hairy cells from hairy cell leukemia patients presenting with pronounced polyclonal hypergammaglobulinemia secrete a factor enhancing IgG synthesis. Clinical Immunology and Immunopathology, 66, 212-218.
33. Netea, M.G., Hoitink, O., Kullberg, B.J., van der Meer, J.W. & Raymakers, R. (2008) Defective interferon-gamma production in patients with hairy cell leukaemia. Netherlands Journal of Medicine, 66, 340-343.
34. Nielsen, B., Braide, I. & Hasselbalch, H. (1992) Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma. Cancer, 70, 2087-2090.
35. Paltiel, O., Adler, B., Barchana, M. & Dann, E.J. (2006) A population-based study of hairy cell leukemia in Israel. European Journal of Haematology, 77, 372-377.
36. Pawson, R., A'Hern, R. & Catovsky, D. (1996) Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha. Leukaemia & Lymphoma, 22, 103-106.
37. Piro, L.D., Carrera, C.J., Carson, D.A. & Beutler, E. (1990) Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New England Journal of Medicine, 322, 1117-1121.
38. Saven, A., Burian, C., Koziol, J.A. & Piro, L.D. (1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood, 92, 1918-1926.
39. Spiers, A.S., Parekh, S.J. & Bishop, M.B. (1984) Hairy-cell leukemia: induction of complete remission with pentostatin (2′-deoxycoformycin). Journal of Clinical Oncology, 2, 1336-1342.
40. Troussard, X., Henry-Amar, M. & Flandrin, G. (1994) Second cancer risk after interferon therapy? Blood, 84, 3242-3244.
41. Troussard, X., Duchenet, V., Cornet, E., Mouchel, D., Malet, M. & Collignon, A. (2009) Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004. Revue d'Epidemiologie et de Sante Publique, 57, 151-158.
42. Westbrook, C.A. & Golde, D.W. (1985) Autoimmune disease in hairy-cell leukaemia: clinical syndromes and treatment. British Journal of Haematology, 61, 349-356.
43. Zinzani, P.L., Pellegrini, C., Stefoni, V., Derenzini, E., Gandolfi, L., Broccoli, A., Argnani, L., Quirini, F., Pileri, S. & Baccarani, M. (2010) Hairy cell leukemia: evaluation of the long-term outcome in 121 patients. Cancer, 116, 4788-4792.